Skip to main content
Gastroenterology Report logoLink to Gastroenterology Report
. 2018 Nov 26;7(3):212–217. doi: 10.1093/gastro/goy041

Outcomes in patients with Fournier’s gangrene originating from the anorectal region with a particular focus on those without perineal involvement

Hong-Cheng Lin 1,2,3, Zu-Qing Chen 4, Hua-Xian Chen 1,2,3, Qiu-Lan He 5, Zhi-Min Liu 1,2,3, Zhi-Yang Zhou 6, Rong Shi 4, Dong-Lin Ren 1,2,3,
PMCID: PMC6573794  PMID: 31217986

Abstract

Background and aim

Fournier’s gangrene (FG) is a fulminant infection in the external genital region and perineum. The present study explored the clinical features of FG originating from the anorectal region, from primary conditions such as anal fistulas and abscesses.

Methods

A retrospective analysis was performed in order to identify the factors associated with clinical outcomes in FG patients derived from two hospitals—the Sixth Affiliated Hospital of Sun Yat-sen University and People’s Hospital Affiliated to Fujian University of Traditional Chinese—over the period from May 2013 to April 2017.

Results

Sixty FG patients were included in this study. The common causative microorganisms cultured were Escherichia coli species. Genital and perirectal regional involvement was evident in 52 and 59 cases, respectively, although the perineum was unaffected in 7 cases (12%), as confirmed by imaging examination and surgical exploration. Management with early radical debridement and broad-spectrum antibiotic therapy is effective with an acceptably sepsis mortality (1.7%). Ten patients underwent protective colostomy. No patient underwent an orchidectomy and required urinary diversion.

Conclusions

FG originating from the anorectal region can be rapidly progressive and life-threatening. Infection can spread superiorly to the genital region without the involvement in perineal tissue. An aggressive surgical debridement of non-viable tissue is essential for satisfactory outcomes and a protective colostomy is not mandatory.

Keywords: Fournier’s gangrene, perianal abscess, anal fistula, protective colostomy

Introduction

Fournier’s gangrene (FG), first described by Fournier in 1883, is a fulminant infection of the external genital region and perineum resultant from mixed aerobic and anaerobic bacteria [1]. It is an uncommon condition that can affect patients of any age and can rapidly progress to a life-threatening stage. The incidence of FG remains low, with reported rates ranging from 1/7500 to 1/2000 in hospitalized patients and with a reported mortality rate of 16% [2]. Diabetes mellitus and immunosuppression are two major risk factors for FG [3], with anorectal and urogenital infections and traumas being amongst the most important etiological predisposing factors [4, 5]. Early diagnosis of this condition with prompt surgical treatment and early antibiotic therapy forms the cornerstone of its clinical management.

In a dedicated colorectal disease hospital, the majority of FG patients referred and managed have an anorectal origin that includes those primarily with perianal abscesses and anal fistulas. Here, infection from an anorectal focus often extends to the perineum and then to the scrotum, with some infections even spreading to the abdominal wall [2]. In our clinical practice of FG, however, some patients with a primary anorectal origin and involvement of the genital and perianal regions had sparing of the neighboring perineal soft tissues—a phenomenon not previously reported. It is postulated that this type of FG may represent a different process of tissue spread than the usual FG variant. The present study reviews our experience in the management of FG originating from the anorectal region, particularly in those without perineal involvement.

Patients and methods

Patients

This retrospective study was reviewed and approved by the Institutional Review Board of the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. All eligible patients with FG admitted to the Sixth Affiliated Hospital of Sun Yat-sen University and People’s Hospital Affiliated to Fujian University of Traditional Chinese from May 2013 to April 2017 were included in the review. The inclusion criteria for this study were patients with a post-operative diagnosis of FG with an anorectal origin. A total of 63 patients with FG were initially identified, with 3 exclusions that were deemed not to have originated from the anorectal region.

Demographic and clinical variables

The patient demographic data, including age, body mass index (BMI), duration of symptoms and location of lesions, were obtained from hospital medical records. Any predisposing factors including diabetes mellitus, alcohol use, paraplegia/hemiplegia, chronic renal failure and epilepsy were recorded. BMI was calculated by dividing body weight (kg) with height squared (m2) and obesity was defined as a BMI > 30 kg/m2. The duration of symptoms was defined as the interval from symptom onset to the first clinical evaluation in hospital. Clinical and laboratory data, including the body temperature, heart rate, respiratory rate and white blood count, were collected. Tachycardia was defined as >100/minute with systolic hypotension defined as a blood pressure <90 mmHg and with tachypnea recorded when there was a respiration rate >20/minute. The body surface area (BSA) involved by the infection was assessed using the burn index [6]. Imaging data (computed tomography [CT] and magnetic resonance imaging [MRI]) were also reviewed, along with the operative characteristics and clinical patient outcomes.

Management

The general principles of FG management included hemodynamic stabilization and the intravenous administration of broad-spectrum antibiotics. Pus or necrotic tissue from the infected region was obtained for culture and sensitivity. Wide-spectrum antibiotic therapy was initiated empirically prior to the results of the microbial culture with modification of antibiotics when appropriate based upon culture sensitivities and the status of control of active infection. Tetanus antitoxin was routinely administered.

Following the correction of the fluid and electrolyte imbalance, a radical debridement was performed incorporating the soft tissues of the penis, scrotum, perineum and perianal regions as well as any other involved soft-tissue territory. Post-operatively, close glucose control was initiated and continued in patients with diabetes mellitus with daily wound irrigation using saline and povidone-iodine solution as well as hydrogen peroxide. Following debridement and the development of responsive granulation tissue, in those patients with scrotal skin loss involving <50% of the scrotal skin, the wounds were secondarily closed. In those patients with more advanced or even total scrotal skin loss, a delayed split-thickness skin graft (STSG) was used with the preferred use of a thicker non-meshed STSG as integumentary cover for penile defects.

Patients were contacted by telephone for a post-operative follow-up with direct questioning concerning wound healing, sphincter function and sexual function.

Statistical analysis

The SPSS version 13.0 (SPSS Inc., Chicago, Illinois) was used for analyses. Descriptive statistics included means and standard deviations or medians and ranges where indicated for continuous factors, as well as frequencies for categorical variables. The Chi-square or Fisher’s exact test was used where appropriate for qualitative variables. A P-value <0.05 was considered statistically significant for all tests.

Results

Among the 60 included patients (56 males and 4 females), 32 (53.3%) were from the Sixth Affiliated Hospital of Sun Yat-sen University and 28 (46.7%) from Fujian Provincial People’s Hospital (Figure 1). The mean age was 53.0 ± 15.9 years. The average BSA involved by the infection was 3.3 ± 3.8%, with a mean BMI of 23.4 ± 3.6 kg/m2. The mean duration of symptoms prior to gangrene was 6.5 ± 3.7 days. The white blood cell counts and neutrophil granulocyte counts were markedly increased in 51 (85.0%) and 53 cases (88.3%), respectively. The predisposing factors and clinical manifestations are listed in Table 1.

Figure 1.

Figure 1.

Participant enrolment and follow-up (flow diagram)

Table 1.

Predisposing factors and clinical manifestations

No. of patients (N = 60)
Predisposing factors
 Anal fistula 1 (1.7%)
 Perianal abscess 42 (70.0%)
 Diabetes mellitus 29 (48.3%)
 Paraplegia/hemiplegia 2 (3.3%)
 Chronic renal failure 4 (6.7%)
 Epilepsy 0
Symptoms and signs
 Scrotal (labia majora) swelling 45 (75%)
 Scrotal (labia majora) pain 41 (68.3%)
 Scrotal (labia majora) redness 42 (70.0%)
 Perineal pain 33 (55.0%)
 Perinal pruritus 1 (1.7%)
 Crepitus 28 (46.7%)
 Fever greater 39°C 4 (6.7%)
 Tachycardia 22 (36.7%)
 Systolic hypotension 0
 Tachypnea 15 (25.0%)

Microorganisms were isolated on culture of the necrotic or purulent tissues in 34 patients while there was no necrotic tissue available for the remaining 26 cases. The common bacterial species isolated were Escherichia coli (55.9%) (Table 2). Only one patient (2.9%) had two organisms grown on the culture. Triple empirical antibiotics, including a third-generation cephalosporin, an aminoglycoside and metronidazole or clindamycin, were used in all the cases with a change in regimen in accordance with the findings of the sensitivity tests and continuance of antibiotic therapy until the active infection was controlled. The mean duration of use of broad-spectrum antibiotics was 15.7 ± 8.5 days (range 6–38 days).

Table 2.

Pathogen culture of the necrotic or purulent tissues

Microorganism No. of patients (N = 34)
Escherichia coli 19 (55.9%)
Enterococcus faecalis 1 (2.9%)
Proteus mirabilis 1 (2.9%)
Klebsiella pneumoniae 1 (2.9%)
Peptostreptococcus 1 (2.9%)
Pseudomonas aeruginosa 1 (2.9%)

CT scans were performed in 49 cases and MRI was conducted in 11 patients. Based upon the imaging data and clinical manifestations, involvement of the genital and perirectal regions was detected in 52 and 59 cases, respectively, while the perineum was specifically not involved in 7 (11.7%) patients. An abscess in the ischiorectal fossa was evident in 47 cases (78.3%). Eighteen (30.0%) patients showed a supralevator abscess extension linked to the ischiorectal fossa via translevator passage. The locations of ancillary lesions are listed in Table 3 . When the internal inguinal ring was dissected in those seven cases in which the perineum was unaffected, purulent fluid was able to be expressed from the proximal end of the inguinal canal where, on exploration, there was a direct communication along the canal into the retropubic space. Although the genital region was involved in all seven cases, the severity of the infection locally was minor, with less purulent fluid emanating from the distal end of the inguinal canal when compared with that found at its proximal end. In each of these cases, the skin, fascia and most of the perineal musculature were unaffected (Figure 2).

Table 3.

Location of lesions

Location No. of patients (N = 60)
Penile shaft 22 (36.7%)
Scrotum (labia majora) 52 (86.7%)
Perineum 53 (88.3%)
Anorectum 59 (98.3%)
Inguinal 29 (48.3%)
Thigh 14 (23.3%)
Supralevator 18 (30.0%)
Ischiorectal fossa 47 (78.3%)
Anterior abdominal wall 18 (30.0%)
Posterior pararenal space 1 (1.7%)

Figure 2.

Figure 2.

Fournier gangrene without perineal involvement. (A) Representative surgical image of genital and anorectal involvement with relative perineal sparing. (B) The MRI showed that infection involved the perianal region and spread to the supralevator space and reach retropubic space (red arrows), but spared most of perineal tissue.

The treatment, including surgery and antibiotic therapy, was generally effective. However, several major complications, including one case of generalized sepsis, one fungal infection, one massive hemorrhage from erosion of an abdominal wall vessel and one septic death, were identified in this cohort. No patient underwent an orchidectomy and required urinary diversion. Ten patients (16.7%) needed a protective colostomy. Vacuum-assisted drainage (VSD) was used in two cases only in our clinical practice. One patient with a colostomy died of delayed sepsis, while all the patients who did not undergo diversion survived; the mortality rate is similar between patients with and without a colostomy (10 vs 0%, P = 0.167). The median interval between the debridement procedure and colostomy closure was 7 months (range 4–12 months). In addition, in this series of all recruited patients, secondary debridement was performed in eight cases (13.3%), with one (1.7%) undergoing debridement on three occasions.

The mean time to oral intake was 4.4 ± 4.6 days and no ileus was observed in the present study. Reconstruction of the scrotum was performed in five cases, with the average time between initial debridement and penoscrotal reconstruction being recorded as 25.3 ± 5.6 days. The wounds were directly closed in 15 cases (25.0%) and a STSG was used in the remaining 45 patients (75.0%). Thinner, durable non-meshed STSG was used in five patients specifically for penile reconstruction. The average time until STSG was 26 days (range 17–64 days).

Follow-up was achieved in 50 patients (83.3%), with a mean follow-up period of 26.9 ± 14.1 months. All patients were in good health at the time of their most recent follow-up.

Discussion

FG is a rare but frequently fatal disease characterized by acute necrotizing fasciitis that develops in the perineum and the external genitalia. Typically, a rapid clinical progression occurs with a mixed aerobic and anaerobic bacterial infection. The present study demonstrated that FG originating in the anorectal region was rapidly progressive and life-threatening. Early diagnosis and aggressive surgical debridement are the mainstays of FG management. A possible route of infection for an anorectal origin can be identified with CT imaging. Further, a protective colostomy for anorectal-derived FG is not mandatory.

In this study, we found several common causative microorganisms, such as E. coli, where most bacteria originated from the bowel even though the bacterial profiles of non-anorectal-derived and anorectal-derived FG are similar [7, 8]. The perceived rate of spread of fascial necrosis caused by mixed organisms has been reported to be as high as 2.536 cm per hour [4], sometimes with a rapid progression to systemic toxicity. The treatment should involve a broad-spectrum antibiotic therapy with, in our opinion, a focus on combating Gram-negative bacteria of gastrointestinal origin. This is accompanied by a timely and radical debridement emergently performed so as to stop the progression of the infection.

Although the diagnosis of FG is often made clinically, early diagnosis can be achieved with a more accurate assessment of the disease extent using emergency CT and MRI, which can also direct the areas of infection that need debridement. An advantage is that the communications between spaces are able to be assessed by reconstructed imagery defining infections spreading along fascial planes along the perineum and beyond. In cases of FG originating from perirectal sepsis, infection frequently spreads along Colles’ fascia and progresses anteriorly along the Dartos fascia to involve the scrotum and the penis [9]. However, in seven cases (12%) in our series, the genital and perirectal regions were involved but the perineum was spared, as confirmed by clinical, radiological concordance and at surgical exploration.

These findings are at variance with the current literature concerning the spread of infection in FG, where it has been suggested that infection can not only spread along fascial planes, but also extend deeply into muscle [10]. Such myonecrosis is usually caused by Clostridial species, although it can occasionally result from virulent E. coli infection [11]. In this event with E. coli culture, it is advised to consider alternative pathways for the progression of local sepsis—a state best defined by CT and MR imaging. Infection with a particularly virulent microorganism or, more commonly, from a combination of microorganisms originating from the perirectal region may also extend as an abscess across the levator plate into the supralevator space, as shown with specialist scanning in 18 cases (30%) in our present study. This demonstrates that mesorectal and seminal vesicular involvement permits spread along the ductus deferens to involve the inguinal region and the scrotum (Figure 3). Further infection can pass superiorly in this plane along Scarpa’s fascia to the anterior abdominal wall (30% in our series) whereas supralevator sepsis can involve both the retrorectal and retroperitoneal spaces where, on CT scan in one of our cases, there was a large focus of gas evident in the posterior aspect of the pararenal space. Although CT and MRI have great specificity in the evaluation of the disease extent in FG [12], they can potentially miss the type of perineal sepsis seen in our study in which the false negative rate when compared with surgical exploration was 11.7% (seven cases).

Figure 3.

Figure 3.

Postulated pathogenetic mechanism of the spread of infection that could involve the perianal region and spread across the levator plate to the supralevator space and then subsequently reach the retropubic space and the inguinal region whilst sparing most of the perineal soft tissues. (A) Bladder; (B) prostate; (C) seminal vesicle; (D) testicle; (E) epididymis; (F) inguinal canal.

In the present study, no patients required an orchidectomy, although the orchidectomy rates in FG have been reported to be up to 25% in some series [13]. This reflects the different origins of blood supply where the testicular artery is a direct branch from the aorta and where the blood supply to the scrotum comes from the pudendal arterial branches of the femoral artery [14]. Once the infection involves the testis, however, this may be indicative of retroperitoneal or intra-abdominal sepsis [15]. In our series, all patients underwent timely and radical debridement, which is an essential part of FG management, with liberal use of the second-look procedure. In this regard, eight patients (13.3%) underwent a second debridement, with one patient (1.7%) undergoing debridement three times. It would seem that the VSD would be specifically beneficial, relieving post-operative pain and shortening the length of hospital stay. Future cases will be managed with the VSD in an effort to determine its clinical value [7].

It still remains controversial whether fecal diversion is needed in patients presenting with FG. Some physicians prefer to perform a routine fecal diversion in these patients in order to decrease wound contamination and to promote faster wound healing [16, 17]. In this respect, Chen and colleagues have reported that, in FG patients with anorectal disease, those undergoing a primary diverting colostomy have a lower mortality rate overall when compared with those undergoing secondary colostomy treatment [18]. This issue is complex, since mortality may better correlate with the initial extent of disease, resulting in a bias of colostomy being associated with worse prognosis cases. Concerning this point, Korkut et al. [19], in a retrospective comparative study, reported that the mortality of patients not needing a stoma was low (7%), but increased to 38% when a stoma was required. It should be remembered that serious stoma-related complications can occur, including wound infection, stoma ischemia, prolonged ileus and evisceration, suggesting that the decision for diversion should be measured (16.7% in this study). In our opinion, a protective colostomy is advisable in order to prevent fecal contamination when there is attendant sphincter dysfunction or involvement, rectal perforation and accompanying immunodeficiency.

In conclusion, FG originating in the anorectal region may be rapidly progressive and life-threatening. The infection may spread superiorly to the genital region without involvement of the perineal soft tissue. An aggressive surgical debridement of all non-viable tissue is essential for successful management of the disease. In our view, a protective colostomy is not mandatory.

Funding

This work was supported by the National Key Clinical Discipline Medical Scientific Research Foundation of Guangdong Province, China (Grant number A2015180), the National Natural Science Foundation of China (Grant number 81603628) and Sun Yat-Sen University Clinical Research 5010 Program (Grant number 2017017).

Acknowledgements

H.-C.L., Z.-Q.C. and D.-L.R. are the principal investigators and responsible for the study design. H.-C.L., Q.-L.H., H.-X.C., Z.-M.L., Z.-Y.Z. and R.S. drafted the manuscript. All authors have read and approved the final version of the manuscript.

Conflict of interest

None declared.

References

  • 1. Fournier JA. Gangrene foudroyante de la verge. Med Pract Par 1883;4:589–93. [Google Scholar]
  • 2. Eke N. Fournier’s gangrene: a review of 1726 cases. Br J Surg 2000;87:718–28. [DOI] [PubMed] [Google Scholar]
  • 3. Ayan F, Sunamak O, Paksoy SM et al. Fournier’s gangrene: a retrospective clinical study on forty-one patients. ANZ J Surg 2005;75:1055–8. [DOI] [PubMed] [Google Scholar]
  • 4. Paty R, Smith AD. Gangrene and Fournier’s gangrene. Urol Clin North Am 1992;19:149–62. [PubMed] [Google Scholar]
  • 5. Yaghan RJ, Al-Jaberi TM, Bani-Hani I. Fournier’s gangrene: changing face of the disease. Dis Colon Rectum 2000;43:1300–8. [DOI] [PubMed] [Google Scholar]
  • 6. Dahm P, Roland FH, Vaslef SN et al. Outcome analysis in patients with primary necrotizing fasciitis of the male genitalia. Urology 2000;56:31–5. [DOI] [PubMed] [Google Scholar]
  • 7. Czymek R, Schmidt A, Eckmann C et al. Fournier’s gangrene: vacuum-assisted closure versus conventional dressings. Am J Surg 2009;197:168–76. [DOI] [PubMed] [Google Scholar]
  • 8. Verit A, Verit FF. Fournier’s gangrene: the development of a classical pathology. BJU Int 2007;100:1218–20. [DOI] [PubMed] [Google Scholar]
  • 9. Robin BL, Ajay KS, Robert AN. Fournier gangrene: role of imaging. Radiographics 2008;28:519–28. [DOI] [PubMed] [Google Scholar]
  • 10. Rye BA, Seidelin C, Dueholm S. Perineal progressive myonercrosis following Thiersch’s operation for rectal prolapse. Ann Chir Gynaecol 1987;76:136–7. [PubMed] [Google Scholar]
  • 11. Levy V, Reed C, Abbott SL et al. Escherichia coli myonecrosis in alcoholic cirrhosis. J Clin Gastroenterol 2003;36:443–5. [DOI] [PubMed] [Google Scholar]
  • 12. Rajan DK, Scharer KA. Radiology of Fournier’s gangrene. AJR Am J Roentgenol 1998;170:163–8. [DOI] [PubMed] [Google Scholar]
  • 13. Hosseini SJ, Hosseini SJ, Rahmani M et al. Fournier gangrene: a series of 12 patients. Urol J 2006;3:165–70. [PubMed] [Google Scholar]
  • 14. Salvino C, Harford FJ, Dobrin PB. Necrotizing infections of the perineum. South Med J 1993;86:908–11. [DOI] [PubMed] [Google Scholar]
  • 15. Scott SD, Dawes RF, Tate JJ et al. The practical management of Fournier’s gangrene. Ann R Coll Surg Engl 1988;70:16–20. [PMC free article] [PubMed] [Google Scholar]
  • 16. Nisbet AA, Thompson IM. Impact of diabetes mellitus on the presentation and outcomes of Founier’s gangrene. Urology 2002;60:775–9. [DOI] [PubMed] [Google Scholar]
  • 17. Rajbhandari SM, Wilson RM. Unusual infections in diabetes. Diabetes Res Clin Pract 1998;39:123–8. [DOI] [PubMed] [Google Scholar]
  • 18. Chen CS, Liu KL, Chen HW et al. Prognostic factors and strategy of treatment in Fournier’s gangrene: a 12-year retrospective study. Changgeng Yi Xue Za Zhi 1999;22:31–6. [PubMed] [Google Scholar]
  • 19. Korkut M, Icoz G, Dayangac M et al. Outcome analysis in patients with Fournier’s gangrene: report of 45 cases. Dis Colon Rectum 2003;46:649–52. [DOI] [PubMed] [Google Scholar]

Articles from Gastroenterology Report are provided here courtesy of Oxford University Press

RESOURCES